Frank Gietzen

2.1k total citations
32 papers, 1.3k citations indexed

About

Frank Gietzen is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Surgery. According to data from OpenAlex, Frank Gietzen has authored 32 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Cardiology and Cardiovascular Medicine, 8 papers in Epidemiology and 5 papers in Surgery. Recurrent topics in Frank Gietzen's work include Cardiomyopathy and Myosin Studies (20 papers), Cardiovascular Function and Risk Factors (11 papers) and Cardiac Arrhythmias and Treatments (7 papers). Frank Gietzen is often cited by papers focused on Cardiomyopathy and Myosin Studies (20 papers), Cardiovascular Function and Risk Factors (11 papers) and Cardiac Arrhythmias and Treatments (7 papers). Frank Gietzen collaborates with scholars based in Germany, Sweden and India. Frank Gietzen's co-authors include Dietmar Bänsch, Michael S. Block, H. Kuhn, Karlheinz Seidl, Jürgen Tebbenjohanns, Jürgen Berger, Sigrid Boczor, Marius Volkmer, Karl Heinz Kuck and Matthias Antz and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and European Heart Journal.

In The Last Decade

Frank Gietzen

31 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frank Gietzen Germany 15 1.1k 225 183 150 86 32 1.3k
Miguel Tamariz Canada 12 563 0.5× 390 1.7× 191 1.0× 110 0.7× 72 0.8× 14 742
Dan Abramov Israel 10 431 0.4× 258 1.1× 70 0.4× 83 0.6× 51 0.6× 19 550
Stefan G. Spitzer Germany 18 826 0.7× 99 0.4× 81 0.4× 62 0.4× 67 0.8× 65 935
Yoshiyuki Hada Japan 14 634 0.6× 130 0.6× 135 0.7× 115 0.8× 78 0.9× 57 820
Gregory A. Misbach United States 15 582 0.5× 356 1.6× 261 1.4× 178 1.2× 88 1.0× 30 795
Anis I. Obeid United States 13 382 0.3× 213 0.9× 200 1.1× 60 0.4× 63 0.7× 38 512
Allan L. Klein United States 11 965 0.9× 112 0.5× 105 0.6× 84 0.6× 360 4.2× 17 1.0k
J.P. van Kuijk Netherlands 14 260 0.2× 254 1.1× 175 1.0× 72 0.5× 96 1.1× 35 449
Muaz M. Abudiab United States 9 672 0.6× 96 0.4× 144 0.8× 138 0.9× 233 2.7× 16 753
Suk‐Jung Choo South Korea 9 265 0.2× 251 1.1× 75 0.4× 61 0.4× 99 1.2× 21 442

Countries citing papers authored by Frank Gietzen

Since Specialization
Citations

This map shows the geographic impact of Frank Gietzen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Gietzen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Gietzen more than expected).

Fields of papers citing papers by Frank Gietzen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Gietzen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Gietzen. The network helps show where Frank Gietzen may publish in the future.

Co-authorship network of co-authors of Frank Gietzen

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Gietzen. A scholar is included among the top collaborators of Frank Gietzen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Gietzen. Frank Gietzen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barth, Sebastian, Mohamed Marwan, Jörg Hausleiter, et al.. (2018). Coronary computed tomography angiography (CCTA) in patients with suspected stable coronary artery disease (CAD): diagnostic impact and clinical consequences in the German Cardiac CT Registry depending on stress test results. International journal of cardiac imaging. 35(4). 741–748. 3 indexed citations
2.
Ene, Elena, Philipp Halbfaß, Karin Nentwich, et al.. (2017). Epikardiale Ablation ventrikulärer Tachykardien. Herzschrittmachertherapie + Elektrophysiologie. 28(2). 212–218. 1 indexed citations
3.
Hamm, Karsten, Michael Zacher, Martina B. Hautmann, et al.. (2016). Influence of experience on procedure steps, safety, and functional results in edge to edge mitral valve repair—a single center study. Catheterization and Cardiovascular Interventions. 90(2). 313–320. 3 indexed citations
4.
Barth, Sebastian, Michael Zacher, Holger Reinecke, et al.. (2016). Decreasing incidence of coronary heart disease in extreme obesity (BMI ≥ 40)—A single centre experience. Obesity Research & Clinical Practice. 11(4). 435–444. 1 indexed citations
5.
Laskey, Warren K., Peter Aspelin, Charles J. Davidson, et al.. (2009). Nephrotoxicity of iodixanol versus iopamidol in patients with chronic kidney disease and diabetes mellitus undergoing coronary angiographic procedures. American Heart Journal. 158(5). 822–828.e3. 58 indexed citations
6.
Schneider, M., Hans Neuser, Jürgen Brunn, et al.. (2008). Magnetic‐Guided Percutaneous Coronary Intervention Enabled by Two‐Dimensional Guidewire Steering and Three‐Dimensional Virtual Angioscopy: Initial Experiences in Daily Clinical Practice. Journal of Interventional Cardiology. 21(2). 158–166. 6 indexed citations
7.
Lawrenz, Thorsten, et al.. (2006). Effect of transcoronary ablation of septal hypertrophy on clinical outcome in hypertrophic obstructive cardiomyopathy associated with atrial fibrillation. Clinical Research in Cardiology. 95(5). 254–260. 5 indexed citations
8.
Kuhn, H., et al.. (2004). Catheter-based therapy for hypertrophic obstructive cardiomyopathy@@@Katheterbehandlung der hypertropisch obstruktiven Kardiomyopathie: Erste Analyse des Krankenhausverlaufes des Deutschen TASH-Registers. Zeitschrift für Kardiologie. 93(1). 23–31. 24 indexed citations
9.
10.
Kuhn, H., et al.. (2004). Catheter-based therapy for hypertrophic obstructive cardiomyopathy. Zeitschrift für Kardiologie. 93(1). 23–31. 29 indexed citations
11.
Faber, Lothar, Hubert Seggewiß, H. Kuhn, et al.. (2002). Catheter interventional septal abiation for hypertrophic obstructive cardiomyopathy: an analysis of the follow-up data from the registry of the german society of cardiology. Journal of the American College of Cardiology. 39. 3–3. 2 indexed citations
12.
Bänsch, Dietmar, Matthias Antz, Sigrid Boczor, et al.. (2002). Primary Prevention of Sudden Cardiac Death in Idiopathic Dilated Cardiomyopathy. Circulation. 105(12). 1453–1458. 427 indexed citations
13.
Kuhn, H., Frank Gietzen, C Leuner, et al.. (2000). Transcoronary ablation of septal hypertrophy (TASH): a new treatment option for hypertrophic obstructive cardiomyopathy. Zeitschrift für Kardiologie. 89(16). IV41–IV54. 37 indexed citations
14.
15.
Kuhn, H. & Frank Gietzen. (1999). Transkoronare Ablation der Septumhypertrophie (TASH): Ersetzt sie die Operation (Myektomie)?. Herz. 24(8). 647–651. 3 indexed citations
16.
Gietzen, Frank, et al.. (1998). Acute and long-term results after transcoronary ablation of septum hypertrophy in hypertrophic cardiomyopathy. Journal of the American College of Cardiology. 31. 182–183.
17.
18.
Figulla, Hans R., et al.. (1996). Diltiazem as adjunct treatment in idiopathic dilated cardiomyopathy. Results of the DiDi-trial. Journal of the American College of Cardiology. 27(2). 141–141. 1 indexed citations
19.
Figulla, Hans R., et al.. (1996). Diltiazem Improves Cardiac Function and Exercise Capacity in Patients With Idiopathic Dilated Cardiomyopathy. Circulation. 94(3). 346–352. 63 indexed citations
20.
Loogen, F, H. Kuhn, Frank Gietzen, et al.. (1983). Clinical course and prognosis of patients with typical and atypical hypertrophic obstructive and with hypertrophic non-obstructive cardiomyopathy. European Heart Journal. 4(suppl F). 145–153. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Miguel Tamariz Breakdown of academic impact, for papers by Dan Abramov Breakdown of academic impact, for papers by Stefan G. Spitzer Breakdown of academic impact, for papers by Yoshiyuki Hada Breakdown of academic impact, for papers by Gregory A. Misbach Breakdown of academic impact, for papers by Anis I. Obeid Breakdown of academic impact, for papers by Allan L. Klein Breakdown of academic impact, for papers by J.P. van Kuijk Breakdown of academic impact, for papers by Muaz M. Abudiab Breakdown of academic impact, for papers by Suk‐Jung Choo
Rankless by CCL
2026